TrialClinical and translational science2017

Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.

Richard L Dunbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.